These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Leuprolide and estrogen versus oral contraceptive pills for the treatment of hirsutism: a prospective randomized study. Azziz R; Ochoa TM; Bradley EL; Potter HD; Boots LR J Clin Endocrinol Metab; 1995 Dec; 80(12):3406-11. PubMed ID: 8530573 [TBL] [Abstract][Full Text] [Related]
5. Chronic treatment regimens for hirsutism in women: effect on blood production rates of testosterone and on hair growth. Casey JH Clin Endocrinol (Oxf); 1975 May; 4(3):313-25. PubMed ID: 125164 [TBL] [Abstract][Full Text] [Related]
7. Physiological estrogen replacement may enhance the effectiveness of the gonadotropin-releasing hormone agonist in the treatment of hirsutism. Carmina E; Janni A; Lobo RA J Clin Endocrinol Metab; 1994 Jan; 78(1):126-30. PubMed ID: 8288696 [TBL] [Abstract][Full Text] [Related]
8. Gonadotrophin-releasing hormone agonist therapy for hirsutism is as effective as high dose cyproterone acetate but results in a longer remission. Carmina E; Lobo RA Hum Reprod; 1997 Apr; 12(4):663-6. PubMed ID: 9159420 [TBL] [Abstract][Full Text] [Related]
9. Oral contraceptive pills, gonadotropin-releasing hormone agonists, or use in combination for treatment of hirsutism: a clinical research center study. Carr BR; Breslau NA; Givens C; Byrd W; Barnett-Hamm C; Marshburn PB J Clin Endocrinol Metab; 1995 Apr; 80(4):1169-78. PubMed ID: 7714086 [TBL] [Abstract][Full Text] [Related]
10. Treatment of seizures with medroxyprogesterone acetate: preliminary report. Mattson RH; Cramer JA; Caldwell BV; Siconolfi BC Neurology; 1984 Sep; 34(9):1255-8. PubMed ID: 6540415 [TBL] [Abstract][Full Text] [Related]
11. [Possible influence of medroxyprogesterone on hirsutism]. de Oliveira RF; Novais L di P; da Costa JF; Lima MB; Castilho C; Azambuja RA; Vieira Mda G; Rodrigues J; Francalanci CC Rev Bras Med; 1972 Apr; 29(4):198-200. PubMed ID: 5049288 [No Abstract] [Full Text] [Related]
12. Comparison of lipid and androgen levels after conjugated estrogen or depo-medroxyprogesterone acetate treatment in postmenopausal women. Barnes RB; Roy S; Lobo RA Obstet Gynecol; 1985 Aug; 66(2):216-9. PubMed ID: 2991832 [TBL] [Abstract][Full Text] [Related]
13. [The concept of the causal therapy of hirsutism]. Schmidt JB Z Hautkr; 1986 Feb; 61(4):187-96. PubMed ID: 2938348 [TBL] [Abstract][Full Text] [Related]
14. A prospective randomized trial comparing low dose flutamide, finasteride, ketoconazole, and cyproterone acetate-estrogen regimens in the treatment of hirsutism. Venturoli S; Marescalchi O; Colombo FM; Macrelli S; Ravaioli B; Bagnoli A; Paradisi R; Flamigni C J Clin Endocrinol Metab; 1999 Apr; 84(4):1304-10. PubMed ID: 10199771 [TBL] [Abstract][Full Text] [Related]
16. New therapeutic approach to the hirsute patient. Boisselle A; Tremblay RR Fertil Steril; 1979 Sep; 32(3):276-9. PubMed ID: 488407 [TBL] [Abstract][Full Text] [Related]
17. Triiodothyronine in the treatment of hirsute girls. Szamatowicz M; Kulikowski M Exp Clin Endocrinol; 1983 Jul; 82(1):15-20. PubMed ID: 6193974 [TBL] [Abstract][Full Text] [Related]
18. Prolonged gynecologic and endocrine manifestations subsequent to administration of medroxyprogesterone acetate during pregnancy. Turner SJ; Mizock GB; Feldman GL Am J Obstet Gynecol; 1966 May; 95(2):222-7. PubMed ID: 5935707 [TBL] [Abstract][Full Text] [Related]
19. Estrogen replacement does not potentiate gonadotropin-releasing hormone agonist-induced androgen suppression in treatment of hirsutism. Tiitinen A; Simberg N; Stenman UH; Ylikorkala O J Clin Endocrinol Metab; 1994 Aug; 79(2):447-51. PubMed ID: 8045961 [TBL] [Abstract][Full Text] [Related]